SCHEMBL2992370

SCHEMBL2992370

CCOc1ccc2c(c1)c(C(=O)C(=O)NC1CCCC1)c(Cl)n2Cc1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
TSHR P16473 2/20 0.41
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41
RGS12 O14924 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
GNAI1 P63096 1/20 0.41
PMP22 Q01453 1/20 0.41
KMT2A Q03164 1/20 0.41
HIF1A Q16665 1/20 0.41
PLA2G2A P14555 1/20 0.41
RAB9A P51151 3/20 0.41
HPGD P15428 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3005102 0.99 LMNA (0.43) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL2992838 0.98 LMNA (0.41) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL3005740 0.96 ALDH1A1 (0.43) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL4386921 0.96 MAPT (0.42) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL3008192 0.91 ALDH1A1 (0.52) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL3001965 0.90 MAPT (0.51) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL2995940 0.90 RAB9A (0.40) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL3004246 0.89 ALDH1A1 (0.52) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL3011718 0.89 PLA2G2A (0.40) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL2995045 0.89 RAB9A (0.41) LMNAALDH1A1MAPTTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8884020-B2 Indole compounds IRONWOOD PHARMACEUTICALS, INC. (US) 2014-11-11 US disclosed
EP-2610244-A1 Indole compounds Ironwood Pharmaceuticals, Inc. (US) 2013-07-03 EP disclosed
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 US disclosed
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 LMNA 3450/4885ALDH1A1 1229/4885MAPT 997/4885
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 LMNA 4089/4885ALDH1A1 648/4885MAPT 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.